Interactions of Putative Estrogens with the Intracellular Receptor Complex in Mouse Leydig Cells: Relationship to Preneoplastic Hyperplasia

Cancer Research

Volumn 48, Issue 1, 1988, Pages 14-18

  Juriansz, R Lloyd ^a   Huseby, Robert A ^a   Wilcox, R Bruce ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE; COUMESTROL; DIENESTROL; DIETHYLSTILBESTROL; EQUILIN; ESTRADIOL; ESTRIOL; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; HEXESTROL; MESTRANOL; NAFOXIDINE; NITROMIFENE; RADIOISOTOPE; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; DNA SYNTHESIS; ETIOLOGY; LEYDIG CELL; LEYDIG CELL HYPERPLASIA; NONHUMAN; PRECANCER; RECEPTOR BINDING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; DNA; ESTROGENS; FEMALE; HYPERPLASIA; LEYDIG CELL TUMOR; LEYDIG CELLS; MALE; MICE; MICE, INBRED BALB C; PRECANCEROUS CONDITIONS; RECEPTORS, ESTROGEN; TESTICULAR NEOPLASMS;

EID: 0023876338     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Andervont, H. B., Shimkin, M. B., and Canter, H. Y. Susceptibility of seven inbred strains and the Fl hybrids to estrogen-induced testicular tumors and occurrence of spontaneous testicular tumors in strain BALB/c mice. J. Natl. Cancer Inst, 25:1069-1081,1960.
2. Gardner, W. U., Pfeiffer, C. S., and Trentin, J. J. Hormonal factors in experimental carcinogenesis. In: F. Homburger (ed.), Physiopathology of Cancer, p. 152. New York: Paul B. Hoeber, 1959.
3. Huseby, R. A. Estrogen-induced Leydig cell tumor in the mouse: a model system for the study of carcinogenesis and hormone dependency. J. Toxicol. Environ. Health, (Suppl.) 1:177-192, 1976.
4. Uchikawa, T., Huseby, R. A., Zain-ul-Abedin, M., and Samuels, L. T. Changes in testicular DNA produced in BALB/c mice by diethylstilbestrol. J. Natl. Cancer Inst, 45:525-533, 1970.
5. Spruance S. L., Wilcox, B., Richards, O. C., Foster, D. N., Huseby, R. A., and Samuels, L. T. DNA synthesis and DNA polymerase activity in Leydig cells of diethylstilbestrol-stimulated mouse testes. Cancer Res., 38:424-430, 1978.
6. Huseby, R. A., and Samuels, L. T. Lack of influence of hypophysectomy on estrogen-induced DNA synthesis in Leydig cells of BALB/c mice. J. Natl. Cancer Inst, 58:1047-1049,1977.
7. Huseby, R. A. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse. Cancer Res., 40:1006-1013,1980.
8. Sato, B., Spomer, W., Huseby, R. A., and Samuels, L. T. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors. Endocrinology, 104:822-831, 1979.
9. Terakawa, N., Huseby, R. A., Fang, S., and Samuels, L. T. Quantitative changes in estrogen receptor produced by chronic DES treatment of two mouse strains differing in susceptibility to Leydig cell tumor induction. J. Steroid Biochem., 16:643-652,1982.
10. Wieder, R., and Shimkin, M. B. An improved method of producing hormone-cholesterol pellets. J. Natl. Cancer Inst., 32:957-958,1964.
11. Schumacher, M., Schafer, G., Lichtenbert, V., and Hilz, H. Maximal steroidogenic capacity of mouse Leydig cells. FEBS Lett, 107:398-402, 1979.
12. Sato, B., Huseby, R. A., and Samuels, L. T. Evidence of a small molecule in mouse Leydig cell tumors which inhibits the conversion of estrogen receptor from 4s to 5s. Endocrinology, 102:545-555,1978.
13. Sanborn, M. M., Rao, B. R., and Korenman, S. G. Interaction of estradiol-17/3 and its specific uterine receptor evidence for complex kinetic and equilibrium behavior. Biochemistry, 70:4955-4960,1971.
14. Katzenellenbogen, J. A., Johnson, H. J., and Carlson, K. E. Studies on the uterine, cytoplasmic estrogen receptor protein. Thermal stability and ligand dissociation rate. An assay of empty and filled sites by exchange. Biochemistry, 12:4092-4099,1973.
15. Anderson, J. N., Clark, J. H., and Peck, E. J., Jr. The relationship between nuclear estrogen binding and uterotrophic responses. Biochem. Biophys. Res. Commun., 48:1460-1468,1972.
16. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193:265-275, 1951.
17. Huseby, R. A., Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression. Cancer Res., 43:5365-5378,1983.
18. Clark, J. H., Peck, E. J., Jr., and Markaverich, B. M. Steroid hormone receptors: basic principles and measurement. In: W. T. Schrader and B. W. O'Malley (eds.), Laboratory Methods Manual for Hormone Action and Molecular Endocrinology, Ed. 8, pp. 1–70. Houston, Texas: Houston Biological Association, 1984.
19. Jensen, E. V., Jacobson, H. I., Flesher, J. W., Saha, N. N., Gupta, G. N., Smith, S., Colucci, V., Shiplacoff, D., Neumann, H. G., DeSombre, E. R., and Jungblut, P. W. Estrogen receptors in target tissues. In: G. Pincus, T. Nakao, and J. F. Tait (eds.), Steroid Dynamics, pp. 133–157. New York, NY: Academic Press, 1966.
20. Williams, I. H. The metabolism of radioactive 17a-ethynylestradiol 3-methyl ether (mestranol) by women. Steroids, 13:539-544, 1969.
21. Attardi, B., and Happe, H. K., Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen. Endocrinology, 119:904-915,1986.
22. Lee, S.-G., and Chen, C. Liver microsomes demethylation of mestranol and some if its effects on drug metabolism. Steroids, 18:565-575,1971.